Trials / Terminated
TerminatedNCT02382679
Vitamin Therapy in Concussion Management: A Randomized Control Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Thomas Jefferson University · Academic / Other
- Sex
- All
- Age
- 11 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy of vitamin therapy in concussion when compared to placebo with respect to multiple endpoints including symptom severity, cognitive performance on computer based neuropsychological testing, post-concussion balance assessment, and post-concussion vestibular-oculomotor function.
Detailed description
To date, very little data exists on the use of vitamin supplementation to aid in the recovery of concussion. Data previously published shows potential benefit of certain vitamins in the management of migraine headache. These vitamins, Vitamin B2 (Riboflavin), Magnesium, Co-Enzyme Q-10, and Omega-3 fatty acids, at dosages described in the literature, are being used based on the migraine literature findings and anecdotal evidence to help treat complaints of headache in concussion management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Experimental: Vitamin Mixture | Vitamins: B2 (riboflavin), magnesium, co-enzyme Q10, Omega 3 fatty acids |
| DIETARY_SUPPLEMENT | Placebo | Non-nutritional non-immunogenic non-allergic oil-based capsule with same appearance, weight and density of active experimental vitamin. |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-05-01
- Completion
- 2016-05-01
- First posted
- 2015-03-09
- Last updated
- 2022-04-13
Source: ClinicalTrials.gov record NCT02382679. Inclusion in this directory is not an endorsement.